Top Companies in Microcarriers Market

The global microcarriers market is projected to reach USD 2.08 billion in 2024 will increase to USD 3.05 billion by 2029, with a compound annual growth rate (CAGR) of 8.0% from 2024 to 2029. The growth of gene therapy market ascribed to major factors such as  increasing demand for cell culture systems in biopharmaceutical and biotechnology applications, technological advancements, and increasing R&D funding. On the other hand, high cost of cell biology research and limitations in the production of high-density cell culture are restraining the market growth.

Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and Danaher Corporation (US) holding the significant global market share and the global microcarriers market is highly cosolidated.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific (US) is a leading player in the microcarriers market. The company has strong brand image, robust product portfolio, and product development focus. The company offers its products through well-established brands such as Gibco, Nunc, Countess, Dynabeads, and HyPerforma. The company focuses on  product launches, expansion, and acquisition to strengthen the position in the market. For example, in September 2023, the company introduced Gibco CTS Detachable Dynabeads, a groundbreaking platform with an innovative active-release mechanism designed for clinical and commercial cell therapy manufacturing.

Merck KGaA (Germany)

Merck KGaA is a leading science and technology company with a strong global presence in more than 120 countries. The company has a portfolio of more than 300,000 life science products that support a broad customer base. Merck has been a prominent player in the life sciences industry, offering various products and services to support researchers and biomanufacturers. The company has a comprehensive portfolio that includes cell culture media, reagents, and other essential tools for bioprocessing. Merck majorly focuses on expansions in key geographies to increase its customer base. In June 2023, Merck KGaA expanded its reagent manufacturing facility in Nantong, China with an investment of about USD 76.5 million.

Danaher Corporation (US)

Danaher Corporation is one of the leading company in the microcarriers market, attributed to a strong product portfolio, recent acquisitions, and partnerships. Danaher Corporation (Cytiva) (US) offers a wide range of products, including microcarriers, bioreactors, media, and reagents, which greatly expanded Danaher’s position and offerings in the microcarriers market. The Pall Corporation subsidiary is also active in this market and offers single-use and stainless steel bioreactors and filtration equipment. In May 2023, Cytiva and the life sciences business of Pall Corporation completed their integration and are now united as one business under the Cytiva brand.

In October 2023, Cytiva opened a new manufacturing facility in Pune, India, which will double its manufacturing capacity in the country. The facility will produce bioprocessing equipment, including tangential flow, virus filtration, and inactivation systems, to support the Indian biopharmaceutical industry.

Related Reports:

Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Beads (Natural (Collagen), Synthetic (Polystyrene)), Application (Vaccine, CGT, Stem Cells) - Global Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com